Related Products
Hepatocarcinoma, 20 cases. Tumor and matched NAT.
131
£596.00
Hepatocarcinoma, 20 cases. Tumor and matched NAT.
131-HLiv-D051Bch-01-GEN
Colon adenocarcinoma, 75 cases. Tumor and matched NAT.
131
£1,092.00
Colon adenocarcinoma, 75 cases. Tumor and matched NAT.
131-HColA150CS02-GEN
Rectum adenocarcinoma (90 cases), tumor and matched NAT.
131
£2,818.00
Rectum adenocarcinoma (90 cases), tumor and matched NAT.
131-HRec-Ade180Sur-05-GEN
Pancreatic adenocarcinoma, 99 cases, tumor and matched NAT.
131
£3,134.00
Pancreatic adenocarcinoma, 99 cases, tumor and matched NAT.
131-HPan-Ade170Sur-01-GEN
Lung carcinoma,92 cases, tumor and matched NAT.
131
£3,134.00
Lung carcinoma,92 cases, tumor and matched NAT.
131-HLugA180Su03-GEN
Hepatocellular carcinoma, 30 cases. Tumor and matched NAT.
131
£778.00
Hepatocellular carcinoma, 30 cases. Tumor and matched NAT.
131-HLivH090PG01-GEN
Lung adenocarcinoma, 75 cases, tumor and matched NAT.
131
£1,074.00
Lung adenocarcinoma, 75 cases, tumor and matched NAT.
131-HLugA150CS02-GEN
Hepatocellular carcinoma, 75 cases. Tumor and matched NAT.
131
£1,232.00
Hepatocellular carcinoma, 75 cases. Tumor and matched NAT.
131-HLivH160CS01-GEN